Staley Capital Advisers Inc Vyne Therapeutics Inc. Transaction History

Staley Capital Advisers Inc

  • $2.31 Billion
  • Q2 2025

A detailed history of Staley Capital Advisers Inc transactions in Vyne Therapeutics Inc. stock. As of the latest transaction made, Staley Capital Advisers Inc holds 51,472 shares of VYNE stock, worth $18,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,472
Previous 51,472 -0.0%
Holding current value
$18,015
Previous $81,000 3.7%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$1.58 - $4.01 $23,700 - $60,150
15,000 Added 41.13%
51,472 $81,000
Q4 2023

Feb 12, 2024
BUY
$2.25 - $4.12 $29,250 - $53,560
13,000 Added 55.39%
36,472 $84,000
Q1 2023

May 10, 2023
SELL
$0.14 - $3.87 $5,463 - $151,038
-39,028 Reduced 62.44%
23,472 $72,000
Q4 2021

Feb 08, 2022
BUY
$0.91 - $1.5 $11,375 - $18,750
12,500 Added 25.0%
62,500 $64,000
Q3 2021

Nov 05, 2021
BUY
$1.39 - $3.47 $17,375 - $43,375
12,500 Added 33.33%
50,000 $70,000
Q2 2021

Aug 09, 2021
BUY
$3.24 - $6.92 $40,500 - $86,500
12,500 Added 50.0%
37,500 $132,000
Q1 2021

May 06, 2021
BUY
$6.34 - $12.68 $158,500 - $317,000
25,000 New
25,000 $171,000

Others Institutions Holding VYNE

# of Institutions
3
Shares Held
51.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $20.3M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Staley Capital Advisers Inc Portfolio

Follow Staley Capital Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Staley Capital Advisers Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email